Retinoblastoma can sometimes come back after successful treatment, but this is rarely the case.

Retinoblastoma most commonly affects children, but in extremely rare cases, it can also occur in adults.

As with other cancers, retinoblastoma is staged using the TNM system, starting at stage I, followed by stages II, III, and IV. The higher the stage, the more advanced the cancer.

One or more of the following symptoms can indicate an occurrence of retinoblastoma:

Whether or not someone is susceptible to developing retinoblastoma mostly depends on two factors. The first is age, as retinoblastoma primarily affects children under the age of three. The second risk factor is genetics, as approximately 41% of children diagnosed with retinoblastoma have inherited the gene that causes the disease (RB1) from their parents.

Retinoblastoma is caused by a genetic mutation in the RB1 gene, which causes eye cells to grow uncontrollably, ultimately causing a tumor to form.

Retinoblastoma is a type of eye cancer that primarily affects children and develops in the retina, the back part of the eye.

CAR T-cells are engineered through a complex laboratory process. First, T-cells are collected from the patient’s blood through leukapheresis. These T-cells are then genetically modified to express chimeric antigen receptors (CARs) on their surface. The genetic modification involves introducing specific genes into the T-cells using viral vectors. These genes encode the CAR proteins, which consist […]

Allogeneic CAR T-cells are derived from a healthy donor’s T-cells rather than the patient’s own cells, which offers several advantages. One key benefit is that allogeneic CAR T-cells can be manufactured in large quantities and stored for off-the-shelf use. This potentially reduces the time required for treatment and can be readily available for patients. Additionally, […]